The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma Medical Health News, 03 Apr 2019 MPM is highly resistant to tyrosine kinase inhibitors and the preferred treatment remains the combination of a platinum-based…